News Detail
London, 11 Oct 2023: Researchers have developed a new blood test that detects early stage ovarian cancer and may determine whether a pelvic mass is benign or cancerous with 91 per cent accuracy, a rate better than existing tests.
The test known as OvaPrint ......
View Details
Source : IANS & DrugsControl Media Services
methylation
HGSOC
ovarian cancer
ovaprint
bodour salhia
health news
Blood
Blood Test
Cancer
Biopsy
Biotechnology
Carcinoma
Cell
CpG
Diagnostic
Diagnostics
DNA
DNA Methylation
Genomic
Genomics
Medicine
Oncology
Preclinical
Research
Surgery
Related News
- IIT-BHU developing med device with potential to cure sclerosis (28-11-2024)
- Three widely used BP medicines Combo, five times more effective than current drugs (19-11-2024)
- More than half of patients with rheumatic, musculoskeletal disease use OTC supplements: Study (18-11-2024)
- One-third of older people and individuals admitted to the hospital experienced ADRs: Study (17-11-2024)
- Antithrombotic coating with sheltered positive charges prevents contact activation by controlling factor XII–biointerface binding (13-11-2024)
- IISc scientists develop enzyme-based solution to break antibiotic-resistant biofilms (13-11-2024)
- Japan performs world's first stem cell-treatment to restore vision (12-11-2024)
- Scientist treated her own cancer with viruses she grew in the lab (12-11-2024)
- Innovative use of silk in medical devices (10-11-2024)
- Three-fold throughput nitrosamine analysis in drug products using SIFT-MS (07-11-2024)